EKSOEkso Bionics Holdings, Inc.

$29M

Q1 2021 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$2M+30.1% YoY

Gross Profit

$1M64.7% margin

Operating Income

-$3M-164.3% margin

Net Income

-$4M-192.1% margin

EPS (Diluted)

$-0.34

QoQ Revenue Growth

-15.3%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$408,000

Balance Sheet

Total Assets

$57M

Total Liabilities

$16M

Stockholders' Equity

$41M

Cash & Equivalents

$50M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$1M	+30.1%
Gross Profit	$1M	$637,000	+93.9%
Operating Income	-$3M	-$5M	+34.3%
Net Income	-$4M	-$3M	-44.8%

Revenue Segments

EksoHealth

$2M90%

EksoWorks

$183,00010%

Geographic Segments

UNITED STATES

$1M55%

Non-US

$869,00045%

EKSO Q1 2021 Earnings — Ekso Bionics Holdings, Inc. Revenue & Financial Results | Market Cap Arena